Home
Solutions
Products
Pricing
Resources
Request Demo
Start Free
Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo
StateStorm

Weekly Updates

LegiStorm is constantly adding new information on the people, places and reports in our database. In the past week, LegiStorm added:

  • 1412 new people
  • 50 new organizations
  • 1514 new photos
  • 1965 job history records for people in our database
  • 586 education records for people in our database
  • 3031 contact addresses, emails and URLs (LinkedIn, Facebook, etc.)
  • 5 new people through the revolving door
  • 257 new policy reports
  • 176 new trips to our privately funded travel database
  • 11857 new press releases
  • 19 new town halls
  • 6 new hearings

Caught Our Eye Rss

» More from Caught Our Eye
» More from our DevBlog

S. 79, Interagency Patent Coordination and Improvement Act of 2023 (CBO Report for Congress)

Premium   Download PDF Now (2 pages)
Congress 118th
Date Requested March 1, 2023
Requested By the Senate Committee on the Judiciary
Date Sent July 6, 2023
Description:
S. 79 would establish the Interagency Task Force on Patents to facilitate communication between the Food and Drug Administration (FDA) and the Patent and Trademark Office (PTO) regarding patents for human drugs and biological products. Through the task force, the FDA and PTO would share information about how each agency reviews applications related to drugs and biologics, any new approvals of drugs and biologics, and scientific trends and developments. The task force also would establish a procedure for the FDA to provide information about drugs and biologics to PTO’s patent examiners and PTO would be required to help the FDA list patents associated with approved drugs and biologics. Finally, within four years of enactment, PTO would need to report to the Congress about the activities of the task force. The costs of the legislation, detailed in Table 1, fall within budget functions 370 (commerce and housing credit) and 550 (health).

« Return to search CBO reports

HomeAbout Us Contact UsPrivacy PolicyTerms of UseJoin Us
© LegiStorm
LegiStorm
2101 L St. NW, Suite 300
Washington, DC 20037
(202) 360-4172 / congress@legistorm.com